The TNFR1 promoter −845G allele was significantly increased in the PTLD transplant group when compared with the healthy control group but not when compared with the transplant control group (51% vs 36%, P=0.01; Table 1). Here, TNFRSF1A is linked to post-transplant lymphoproliferative disease.